Top compounds associated with response to YJEFN3


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.095 0.008
mRNA Bortezomib gCSI pan-cancer AAC 0.16 0.008
mRNA MST-312 CTRPv2 pan-cancer AAC 0.093 0.008
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.01
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.01
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.076 0.01
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.01
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.01
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.01
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.089 0.01
Download CSV